Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Open Label Extension Study for Subjects That Complete Study MP-101-CL-001

NCT02246816 is registered in ClinicalTrials.gov with Marathon Pharmaceuticals, LLC as lead sponsor.

NCT NCT02246816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02246816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Open Label Extension Study for Subjects That Complete Study MP-101-CL-001
Lead sponsor
Marathon Pharmaceuticals, LLC
Phase
Phase 3
Overall status
Withdrawn
Start date
February 28, 2015
Completion date
February 28, 2018
Enrollment
0 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sbs, short bowel syndrome, short gut, short gut syndrome